171 Preclinical studies support therapeutic application of the leukemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer

by Satwinder Kaur Singh, Maho Nagasawa, Remco Bos, Haoxiao Zuo, Kiave Yune Ho Wang Yin, Marie-José van Lierop, Sebastien Tabruyn, Erik Manting, Marco de Bruyn, Hans Nijman
Published 2020-11-01